What Argonaute does

Credit: COURTESY OF LEEMOR JOSHUA-TOR" /> Credit: COURTESY OF LEEMOR JOSHUA-TOR Greg Hannon's group at Cold Spring Harbor Laboratory was one of many labs scrambling to identify Slicer, the enzyme doing the cutting in RNA-mediated interference. Using biochemical mutagenesis, in vivo knockouts, and enzymatic assays, they had all but pegged Argonaute2. But, says Hannon, "We were stuck ? We could go right up to the edge of saying it was Argonaute without actually saying it." Just bef

Written byJuhi Yajnik
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Greg Hannon's group at Cold Spring Harbor Laboratory was one of many labs scrambling to identify Slicer, the enzyme doing the cutting in RNA-mediated interference. Using biochemical mutagenesis, in vivo knockouts, and enzymatic assays, they had all but pegged Argonaute2. But, says Hannon, "We were stuck ? We could go right up to the edge of saying it was Argonaute without actually saying it."

Just before he accepted defeat, however, a CSHL colleague, Leemor Joshua-Tor, invited him into a darkened room and gave him a pair of 3D glasses. She'd solved the crystal structure of Argonaute, and it revealed a structural homology to RNAse H providing guidance for targeted mutagenesis. "There's just no substitute for when you see it sitting there in 3D," Hannon says. The labs published their milestone findings together in 2004.1,2 "Crystal structures are often important for establishing biological frameworks," says Tom Cech at Howard Hughes Medical ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies